The U.S. pharmaceutical industry is pushing to revamp the new law that allows Medicare to negotiate prices for its costliest ...

The Inflation Reduction Act (the Act) of 2022 was controversial at the time the Act was signed into law and remains so. To date, multiple ...

The Inflation Reduction Act is unlikely to generate savings for taxpayers, while disrupting the market and creating perverse ...

The U.S. pharmaceutical industry is attempting to delay the timeline for Medicare's drug price negotiations following the ...

With fewer Part D plans and a $2,000 out-of-pocket cap, beneficiaries must rethink their Medicare drug coverage for 2025.

A record-low number of Medicare Part D plans could cause greater Medicare Advantage enrollment, which may not be a good thing ...

Big changes are coming to Medicare in 2025, and they could make a major difference in your prescription drug costs. Thanks to the Inflation Reduction Act, Medicare beneficiaries will see the most ...

With policy makers focusing on the role of drug manufacturers, almost no attention has been paid to the way in which ...

The Centers for Medicare & Medicaid Services is attempting to cover anti-obesity medications under Medicare Part D and ...

They need to use their newfound power to repeal the so-called Inflation Reduction Act in its entirety. Democrats passed the ...

The panel focused on the provisions of the Inflation Reduction Act that aim to lower prescription drug prices under Medicare.

Seniors in metro Detroit and across Michigan have an opportunity to sign up for the right Medicare plan during open ...